The assessment available on the Fridays website does not create a doctor-patient relationship. Clinical Services are provided by OpenLoop Healthcare Partners, PC and other networks who determine eligibility for GLP-1 treatment based on medical history and assessment responses. Providers retain full discretion to prescribe or decline compounded GLP-1 medications. Compounded medications offered through Fridays are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. Results may vary and depend on individual adherence, provider guidance, and lifestyle changes. Fridays does not manufacture compounded medications, and product appearance may differ from website images. Click here for a list of partner pharmacies. Fridays partners with certified U.S. pharmacies to ensure high standards of safety and quality. Medication costs are included in the Fridays program. Zepbound is FDA-approved for chronic weight management; Ozempic is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight management. All trademarks are the property of their respective owners. Unless otherwise noted, results reflect Fridays patient experiences rather than public clinical studies.

**Our success rate reflects recent internal fulfillment and delivery performance for paid orders during the current quarter. Rates may vary based on pharmacy capacity, state regulations, and individual order details. This figure does not represent clinical outcomes or individual results and is subject to change as new data becomes available. Written prescription or weight loss results are not guaranteed.

By using our services, you agree to our Terms & Conditions. For information on refunds, please visit our Refund Policy.